{"journal": "Neurobiol Aging", "PMID": "25649022", "goal": [["We sought to investigate this using 11 C-DASB PET, a marker of SERT binding, and 11 C-raclopride PET, a marker of dopamine D2 receptor availability which is influenced by rises in synaptic dopamine levels after a medication challenge with levodopa.", {"pattern": {"sp_index": 85, "pred": ["sought"], "cds": {"PET": 2}, "sub": ["We"], "nes": {"PET": 2, "SERT": 1}}, "sp": 2, "ne": 16, "cd": 1, "sid": "32", "total": 19, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}]], "findings": [["We found normal levels of GPi SERT binding in PD patients with LIDs, which were 23%e29% raised compared with PD patients with a stable response to levodopa.", {"pattern": {"sp_index": 3, "pred": ["found"], "cds": {"%": 1}, "sub": ["We"], "nes": {"GPi": 1, "LIDs": 1}}, "sp": 9, "ne": 8, "cd": 0, "sid": "112", "total": 17, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}], ["Because it has been suggested that exogenous dopamine can be converted and stored in serotonergic terminals, and be released as a false neurotransmitter (Carta et al., 2010; Lindgren et al., 2010), we studied GP D2 receptor availability and indirectly dopamine release with a double 11 C-raclopride PET experiment.", {"pattern": {"sp_index": 100, "pred": ["studied"], "cds": {"experiment": 1}, "sub": ["we"], "nes": {"PET": 1, "Carta": 1, "GP D2": 1}}, "sp": 2, "ne": 16, "cd": 0, "sid": "124", "total": 18, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}], ["We found no difference in GP D2 receptor availability between PD patients and healthy control subjects (Fig. 3A).", {"pattern": {"sp_index": 3, "pred": ["found"], "cds": {}, "sub": ["We"], "nes": {"GP D2": 1}}, "sp": 9, "ne": 0, "cd": 0, "sid": "125", "total": 9, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}], ["We found that after levodopa administration there was a significant decrease of 11 C-raclopride binding in both GP segments in patients with LIDs, but not in patients with a stable levodopa response, indicating a greater dopamine release in patients with LIDs leading to reduced D2 availability.", {"pattern": {"sp_index": 3, "pred": ["found"], "cds": {"binding": 1}, "sub": ["We"], "nes": {"LIDs": 2}}, "sp": 9, "ne": 2, "cd": 0, "sid": "151", "total": 11, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}]], "method": [["We studied 12 PD patients without LIDs, Received in revised form 19 November 2014 12 PD patients with LIDs, and 12 healthy control subjects.", {"pattern": {"nes": {"Received": 1, "LIDs": 2}, "cds": {"patients": 2, "subjects": 1, "November": 1}}, "sp": 0, "ne": 2, "cd": 152, "sid": "3", "total": 154, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}], ["We recruited 24 nondemented and nondepressed PD patients from UK university hospital movement disorder clinics who ful- filled the UK Brain Bank criteria for PD ( Hughes et al., 1992).", {"pattern": {"sp_index": 16, "pred": ["recruited"], "cds": {"patients": 1}, "sub": ["We"], "nes": {"Hughes": 1, "UK": 1}}, "sp": 5, "ne": 1, "cd": 126, "sid": "33", "total": 132, "doc_id": "./anns_v2/Smith et al., (2015) - The role of pallidal serotonergic function in PD dyskinesias. A PET study._annotated_ann.json"}]]}